NCT05166577 2025-03-12Nanatinostat Plus Valganciclovir in Advanced EBV+ Solid Tumors and in Combination With Pembrolizumab in EBV+ RM-NPCViracta Therapeutics, Inc.Phase 1 Terminated26 enrolled 23 charts